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carotid plaque surface (smooth, irregular, ulcerated), NIHSS
groupscorebefore surgery (0orTIA,1-3,4-6,7)andpresence
of ischemic lesions at preoperative CT scans for analysis. Signifi-
cance threshold was set at P.05.
Results: Eighty-three patients out of 203 presented pre-
operative ischemic brain lesions (40.9%). In 48.3% of patients
an irregular plaque surface was recorded, in 41.8% a ulcerated
surface and in 9.9% a smooth surface. At between NHISS
groups analysis ulcerated plaque surface wasmore frequent in
TIA patients (P .05). In those patients the presence of ulcer
in the plaque surface was strongly related to absence of isch-
emic brain lesions (P  .05). In stroke patients (NIHSS0)
the ulcerated or irregular plaque surface was slightly signifi-
cantly associated to presence of preoperative brain ischemic
lesions, particularly in NIHSS 1-3 group patients (P  .08).
Conclusions: Aside from stenosis percentage, neurolog-
ical transient and permanent brain symptoms are highly re-
lated to carotid plaque surface. Ulcerated carotid plaque sur-
face canbe responsible for plaque’smicro-debris embolizationor
fresh thrombus formation whose brain damagemechanisms can
lead to different neurological symptoms and CT scans findings.
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Objectives:To identify risk factors compromising 3 years
survival in treated patients with asymptomatic carotid disease
in complying with recently updated guidelines from the Soci-
ety for Vascular Surgery.
Methods: Outcomes of 504 patients who underwent
carotid intervention for asymptomatic carotid disease in 10
years (1999-2008) were analyzed. Hospital computerized
medical records were reviewed. Social Security Death Index
was queried for mortality. Patients lost to follow up before
3 years post procedure were excluded. After multivariable
Cox regression analysis was done, a score was assigned for
each risk factor (RF): hazard ratio (HR) 1.5-2.0  RF 1;
HR 2.1-3.0  RF 2; HR 3.1-4.0  RF 3. Then a Kaplan
Meier plot analyzed survival differences.
Results: Fifteen percent of the patients did not survive
beyond 3 years post procedure. Age  80 years (HR 2.0,
P  .01, RF  1), Chronic obstructive pulmonary disease
(HR 3.6, P  .001, RF  3), Chronic kidney disease
(CKD) stage 3 (HR 2.0 P  .07, RF  1), CKD stage 4
(HR 3.3, P  .04, RF  3), Coronary artery disease (HR
2.46, P  .001, RF  2) and Diabetes Mellitus (HR 1.8,
P  .02, RF  1) negatively influenced 3 year survival.
Thirty days mortality rate was 0.9% and was not influenced
by score values; however, a cumulative score  3 was
associated with 3 year survival of 93%.
Conclusions: Despite low 30 day mortality rate, in-
creasing risk factors are associated with decreased 3 year
survival. This finding may impact clinical decision for man-
agement of asymptomatic carotid disease.
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Objectives: To review retrospectively records of patients
treated with carotid artery stenting (CAS) to investigate correla-
tions between clinical variables, distal protection filter (DPF)
characteristics, and 30-day peri/post-procedural outcomes.
Methods: This is a multicenter, single-arm study of
DPF-protected CAS in the Pittsburgh region between
2000 and 2011. Analysis of peri/post-procedure complica-
tions included myocardial infarction (MI), transient isch-
emic attacks (TIA), stroke, death, and a composite of all
adverse events (AE). Characteristics for the DPFs were
previously determined in vitro and were used to find corre-
lations with CAS outcomes. Univariate, multivariate, and
goodness-of-fit analyses were performed.
Results: 731 CAS procedures employing six different
DPF were analyzed. Peri/post-procedural AE included 19
TIAs (2.6%), 38 strokes (5.2%), 1 MI (.1%), 19 deaths
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(3.6%) and a total of 61 patients with complications (8.3%).
Univariate analysis for filter design characteristics showed
that the composite of AE was negatively associated with
both vascular resistance (P  .01) and eccentricity (P 
.02), and positively associated with porosity (P  .0007),
number of pores (P  .005), and pore density (P  .001).
Multivariate analysis and the goodness-of-fit test revealed
that history of congestive heart failure (CHF), stroke, and
TIA (each with OR 1) led to a good-fit model P value of
.72 for peri/post-procedural AE. Multivariate analysis was
inconclusive for all filter design characteristics.
Conclusions: The following filter design characteristics
are independently significant for lower peri/post-procedural
AEs: higher vascular resistance, concentric in shape, greater
capture efficiency, lower porosity, lower number of pores and
lower pore density. This information can be used when con-
sidering the desirable design characteristics of future DPFs,
but our data also demonstrate that the patient’s clinical fea-
tures have overriding importance as predictors of AEs.
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Objectives: Gender differences in the presentation of
patients undergoing CEA and CAS are not well studied.
Women have been shown to benefit less from revascular-
ization for asymptomatic carotid disease. Therefore, we
analyzed a regional database to identify gender differences
in patient presentation for CEA and CAS.
Methods: We used the Vascular Study Group of New
England database to identify all patients undergoing CEA
or CAS. We analyzed demographics, comorbidities, symp-
tom status, and outcomes in men and women.
Results: We identified 9376 patients: 8852 CEA and
524 CAS. Men comprised 60% of the study group. Mean
age was similar at 69 years. Women were more likely to be
current smokers with COPD and had less heart disease and
prior CABG/PCI. For CEA women were more likely to be
asymptomatic than men (70% vs 65%; P.001). Of asymp-
tomatic patients, a similar proportion had carotid stenoses
80% (74.3% in women vs 72.5% in men; P  .11). Both
symptomatic and asymptomatic women had similar rates of
any stroke or death compared tomen (symptomatic 2.2% vs
2.1%; P  .81 and asymptomatic 0.9% vs 0.9%; P  .76).
Conclusions: Despite prior data suggesting women
benefit less from carotid revascularization for asymptomatic
carotid disease, 70% of revascularizations were performed
in asymptomatic women. Stroke and death rates compare
favorably to randomized controlled trials for both symp-
tomatic and asymptomatic patients.
Table. Demographics, comorbidities, and symptom
status in patients undergoing CEA and CAS
Men Women P value
Age (years) 69.4 69.6 0.27
Current smoker 28.4% 33.2% .001
COPD 21.6% 25.2% .001
HTN 87.3% 89.1% .01
Diabetes 31.2% 31.8% 0.54
Heart disease 37.6% 27.8% .001
Prior CABG/PCI 37.1% 24.5% .001
Dialysis 0.5% 0.5% 0.81
Symptomatic 35.1% 30.4% .001
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Objectives: Duplex ultrasound is the most commonly
performed diagnostic modality for the detection of carotid
artery stenosis. This noninvasive technique has excellent
sensitivity but can sometimes lead to a false positive diag-
nosis of severe stenosis and subsequently unwarranted end-
arterectomy. We therefore aimed to improve the specificity
of duplex ultrasound for high-grade stenosis.
Methods: A retrospective review was performed for pa-
tients who underwent both carotid duplex ultrasound and
CTA between 2000 and 2009. The NASCET technique was
used to calculate percent stenosis and duplex ultrasound ve-
locities were recorded. A logit regression model was built to
predict severe stenosis using the combination of peak systolic
velocity (PSV), end-diastolic velocity (EDV), and the ratio of
PSV at stenosis to PSV at the common carotid.
Results: A total of 610 vessels were analyzed yielding
31 datapoints for severe and 579 for 80% stenosis. Index
values were calculated for each carotid duplex combination
using the logit formula generated by the model
(-6.413PSV*0.00851EDV*0.0224Ratio*0.1166).
The calculated logit regression formula was transformed to
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